Analyst Ratings for Seres Therapeutics (MCRB)
MCRB Rating Summary
MCRB Price Target Summary
- Highest: $22.00 (Canaccord)
- Lowest: $12.00 (H.C. Wainwright)
- Average: $17.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$17.00 (+242.1%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$17.00 (+242.1%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | H.C. Wainwright | Matthew Keller | New Coverage | Buy (N/A) |
12.00 (N/A) |
6.60 (4.97) |
-24.7% | Details |
| 5/8/2025 | Chardan | Keay Nakae | Downgrade | Neutral (Buy) |
6.00 (N/A) |
8.29 (4.97) |
-40.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
